Literature DB >> 11472344

In vivo expansion of the endogenous B-cell compartment stimulated by radiation and serial bone marrow transplantation induces B-cell leukaemia in mice.

T L Holyoake1, M G Freshney, K Samuel, J Ansell, G E Watson, E G Wright, G J Graham, I B Pragnell.   

Abstract

Chronic lymphocytic leukaemia (CLL) is a malignancy of CD5(+) B cells. This B-cell lineage is established during ontogeny and replenished by the process of self-renewal. Spontaneous and induced leukaemias that frequently affect this lineage are thought to arise as a result of the frequent cell division required to maintain the population throughout adulthood and in response to repeated exposure to environmental antigens. In a series of bone marrow transplant (BMT) experiments performed in B6D2F1 mice, B-cell leukaemia occurred in recipients of serially transplanted syngeneic bone marrow. This study was therefore designed to determine the frequency and phenotype of the observed leukaemia. Male donor cells were initially transplanted into lethally irradiated female hosts and secondary (2 degrees ) BMT was performed at 3 months. At 1, 2, 3 and 16 months following primary (1 degrees ) BMT, and when 2 degrees BMT recipients developed leukaemia, animals were sacrificed and their tissues extensively examined. These analyses confirmed a host-derived CD5(+) transplantable B-cell leukaemia that was initiated in 50% of 1 degrees BMT recipients. With serial passage, the leukaemia became more aggressive and lost CD5 expression, suggesting transformation to a high-grade leukaemia/lymphoma. This previously unreported observation suggests that the combination of radiation and subsequent serial transplantation induces a proliferative stress to the host B-cell compartment that is causative in leukaemic transformation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11472344     DOI: 10.1046/j.1365-2141.2001.02903.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  2 in total

1.  Patient-driven discontinuation of tyrosine kinase inhibitors: single institution experience.

Authors:  Ohad Benjamini; Hagop Kantarjian; Mary Beth Rios; Elias Jabbour; Susan O'Brien; Preetesh Jain; Marylou Cardenas-Turanzas; Stefan Faderl; Guillermo Garcia-Manero; Farhad Ravandi; Gautam Borthakur; Alfonso Quintas-Cardama; Jorge Cortes
Journal:  Leuk Lymphoma       Date:  2013-09-10

2.  DNA bar coding and pyrosequencing to analyze adverse events in therapeutic gene transfer.

Authors:  Gary P Wang; Alexandrine Garrigue; Angela Ciuffi; Keshet Ronen; Jeremy Leipzig; Charles Berry; Chantal Lagresle-Peyrou; Fatine Benjelloun; Salima Hacein-Bey-Abina; Alain Fischer; Marina Cavazzana-Calvo; Frederic D Bushman
Journal:  Nucleic Acids Res       Date:  2008-04-14       Impact factor: 16.971

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.